Abstract:This work reviews cross‐species paradigms with validity for testing positive valence systems used in clinical populations, identified by the National Institute for Mental Health (NIMH) Research Domain Criterion (RDoC) initiative. Tests available for rats and mice are discussed, including whether they have evidence for face, predictive, or neurobiological validities. A focus is placed on touchscreen tests, but all operant tasks are included in the discussion, and future tests are recommended. Functions associated with processing reward‐related information are fundamental drivers of motivation, learning, and goal‐directed behavior. Such functions have been classified as the positive valence system under the Research Domain and Criteria (RDoC) criteria and are negatively impacted across a range of psychiatric disorders and mental illnesses. The positive valence system is composed of three comprehensive categories containing related but dissociable functions that are organized into either Reward Responsiveness, Reward Learning, or Reward Valuation. The presence of overlapping behavioral dysfunction across diagnostic mental disorders is in‐part what motivated the RDoC initiative, which emphasized that the study of mental illness focus on investigating relevant behavior and cognitive functions and their underlying mechanisms, rather than separating efforts on diagnostic categories (i.e., transdiagnostic). Moreover, the RDoC approach is well‐suited for preclinical neuroscience research, as the rise in genetic toolboxes and associated neurotechnologies enables researchers to probe specific cellular targets with high specificity. Thus, there is an opportunity to dissect whether behaviors and cognitive functions are supported by shared or distinct neural mechanisms. For preclinical research to effectively inform our understandings of human behavior however, the cognitive and behavioral paradigms should have predictive, neurobiological, and pharmacological predictive validity to the human test. Touchscreen‐based testing systems provide a further advantage for this endeavor enabling tasks to be presented to animals using the same media and task design as in humans. Here, we outline the primary categories of the positive valence system and review the work that has been done cross‐species to investigate the neurobiology and neurochemistry underlying reward‐related functioning. Additionally, we provide clinical tasks outlined by RDoC, along with validity and/or need for further validation for analogous rodent paradigms with a focus on implementing the touchscreen‐based cognitive testing systems.

Structured evaluation of rodent behavioral tests used in drug discovery research

Rodent tests of depression and anxiety: Construct validity and translational relevance

Animal tests for anxiety-like and depression-like behavior in rats

Using tests and models to assess antidepressant-like activity in rodents

Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice

The NEWMEDS Rodent Touchscreen Test Battery for Cognition Relevant to Schizophrenia

Nature and nurture: Comparing mouse behavior in classic versus revised anxiety‐like and social behavioral assays in genetically or environmentally defined groups

Depression Assessment in Clinical Trials and Pre-clinical Tests: A Critical Review

Seminatural environments for rodent behavioral testing: a representative design improving animal welfare and enhancing replicability

Development and Characterization of an Automated Behavioral Assessment Platform for the Göttingen Minipig

Beyond the three-chamber test: toward a multimodal and objective assessment of social behavior in rodents

Behavioral Testing Design for Evaluation of Cognitive Disabilities

Tests for learning and memory in rodent regulatory studies

The need for guidance in antidepressant drug development: Revisiting the role of the forced swim test and tail suspension test

Measuring Locomotor Activity and Behavioral Aspects of Rodents Living in the Home-Cage

Translational validity of neuropsychological tasks of sustained attention between rodents and humans: A systematic review of three rodent tasks

A translational rodent assay of affective biases in depression and antidepressant therapy

The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice

Issues in the design, analysis, and application of rodent developmental neurotoxicology studies

Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics

Cross‐species translational paradigms for assessing positive valence system as defined by the RDoC matrix